Regentis Biomaterials RGNT
NYSE RGNT
$1.83 +0.01 (+0.55%)
At close: Oct 2, 2026 · 4:00 PM EDT

Regentis Biomaterials (RGNT) Cash & Equivalents (2024 - 2026)

Updated

Regentis Biomaterials (RGNT) recorded Cash & Equivalents of $8.95 million in Q2 2026.

Analysis

Regentis Biomaterials (RGNT) Cash & Equivalents (2024 - 2026) Analysis & Trends

At the end of FY2025, Regentis Biomaterials reported Cash & Equivalents of $7.38 million.

  • Across earlier years, Cash & Equivalents came in at $229,000 in FY2024 (-81.5%) and $1.24 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Thermo Fisher Scientific 241.25 Bn 220.40 Bn 4.88 Bn 4.06 Bn
2 Abbott Laboratories 167.33 Bn 138.41 Bn 7.27 Bn 5.10 Bn
3 Danaher 148.83 Bn 132.65 Bn 3.61 Bn 4.35 Bn
4 Intuitive Surgical 142.00 Bn 121.55 Bn 1.96 Bn 2.76 Bn
5 Medtronic 110.70 Bn 76.57 Bn 6.34 Bn 1.69 Bn
6 Stryker 104.72 Bn 90.84 Bn 4.50 Bn 3.39 Bn
7 Boston Scientific 62.66 Bn 57.67 Bn 3.85 Bn 539.00 Mn
8 Edwards Lifesciences 49.13 Bn 33.24 Bn 1.35 Bn 2.91 Bn
9 Becton Dickinson 48.51 Bn 45.66 Bn 2.32 Bn 708.00 Mn
10 Regentis Biomaterials 1.03 Mn -7.92 Mn - 8.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.95 Mn
Dec 31, 2025 7.38 Mn
Dec 31, 2024 229,000.00
API Access

Regentis Biomaterials Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RGNT&period=max&api_key=YOUR_API_KEY